Catheter-Related Bloodstream Infection Global Market Report 2024 - By Demand, Share, Size, Trends, Forecast To 2033

Global catheter-related bloodstream infection market size is expected to reach $1.93 billion by 2028 at a rate of 6.1%, segmented as by treatment, antibiotic lock therapy, anti-microbial agents

Sep 2, 2024 - 11:12

0 3

Catheter-Related Bloodstream Infection Global Market Report 2024 - By Demand, Share, Size, Trends, Forecast To 2033

catheter-related bloodstream infection market

The catheter-related bloodstream infection market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing healthcare-associated infections (hais), rising awareness and training, enhanced awareness and training programs on infection control practices, expansion of healthcare infrastructure, increase in geriatric population, supportive government policies and initiatives. Major trends in the forecast period include biomaterial innovations, smart catheter technology, the development of more effective catheter lock solutions with advanced antimicrobial properties, innovations in sterilization processes for catheters, and automated flushing systems.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report

Segmentation & Regional Insights
The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneuminiae), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginsa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp

Major Driver Impacting Market Growth
The rising prevalence of hospital-acquired infections is expected to propel the growth of the catheter-related bloodstream infection market going forward. Hospital-acquired infections (HAIs) are infections that patients acquire while receiving treatment for other conditions within a healthcare setting, typically manifesting 48 hours or more after admission. An increase in hospital-acquired infections can be attributed to various factors such as antimicrobial resistance, inadequate infection control measures, and patient susceptibility. Catheter-related bloodstream infections contribute significantly to hospital-acquired infections due to their invasive nature and potential for microbial colonization, posing risks to patients with indwelling catheters. For instance, in January 2023, according to the National Library of Medicine, a US-based biomedical library, the global healthcare-associated infection (HAI) rate was 0.14%, increasing annually by 0.06%. Therefore, the rising prevalence of hospital-acquired infections will drive the growth of the catheter-related bloodstream infection market.

Key Industry Players
Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

The catheter-related bloodstream infection market report table of contents includes:
1. Executive Summary
2. Catheter-Related Bloodstream Infection Market Characteristics
3. Catheter-Related Bloodstream Infection Market Trends And Strategies
4. Catheter-Related Bloodstream Infection Market - Macro Economic Scenario
5. Global Catheter-Related Bloodstream Infection Market Size and Growth
..................................................
32. Global Catheter-Related Bloodstream Infection Market Competitive Benchmarking
33. Global Catheter-Related Bloodstream Infection Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Catheter-Related Bloodstream Infection Market
35. Catheter-Related Bloodstream Infection Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Click Here To See More